CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 80 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $187,000 | -92.9% | 20,269 | -88.6% | 0.01% | -90.9% |
| Q3 2018 | $2,624,000 | +19.1% | 177,372 | +37.1% | 0.06% | +31.0% |
| Q2 2018 | $2,203,000 | +10.8% | 129,409 | +49.0% | 0.04% | 0.0% |
| Q1 2018 | $1,988,000 | -61.7% | 86,828 | -56.3% | 0.04% | -62.5% |
| Q4 2017 | $5,195,000 | +1789.1% | 198,881 | +909.0% | 0.11% | +2140.0% |
| Q2 2017 | $275,000 | +16.0% | 19,711 | +42.1% | 0.01% | -16.7% |
| Q1 2017 | $237,000 | -52.2% | 13,876 | -71.7% | 0.01% | -60.0% |
| Q3 2016 | $496,000 | -77.4% | 49,104 | -74.9% | 0.02% | -79.2% |
| Q2 2016 | $2,194,000 | -23.1% | 195,384 | -6.5% | 0.07% | -12.2% |
| Q1 2016 | $2,853,000 | -52.4% | 208,894 | -33.5% | 0.08% | -41.8% |
| Q4 2015 | $5,993,000 | – | 313,938 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |